

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.47885158 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.47885158 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.15792040 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.15792040 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.59563629 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.03135628 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.82817944 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.82817944 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.82817944 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.78724381 |
| 11 | proteasome assembly (GO:0043248) | 5.76134908 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.72908806 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.72012403 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.52286309 |
| 15 | cysteine metabolic process (GO:0006534) | 5.44860351 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.43519918 |
| 17 | urea cycle (GO:0000050) | 5.27315182 |
| 18 | urea metabolic process (GO:0019627) | 5.27315182 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.25448038 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.23049388 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.22072393 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.12361695 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.06952824 |
| 24 | protein carboxylation (GO:0018214) | 5.06952824 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.04105405 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.00443036 |
| 27 | lysine catabolic process (GO:0006554) | 5.00236691 |
| 28 | lysine metabolic process (GO:0006553) | 5.00236691 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.97079549 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.92359881 |
| 31 | bile acid metabolic process (GO:0008206) | 4.89561090 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.86808205 |
| 33 | regulation of complement activation (GO:0030449) | 4.79777164 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.78419565 |
| 35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.74314422 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74284098 |
| 37 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.72020060 |
| 38 | alpha-amino acid catabolic process (GO:1901606) | 4.65420435 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.63367134 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.59871792 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.59684765 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.59656110 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.58911282 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.58911282 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.58911282 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.58680763 |
| 47 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.50471577 |
| 48 | glycine metabolic process (GO:0006544) | 4.46532823 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 4.42958935 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.42717516 |
| 51 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.42632533 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.40042034 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.40042034 |
| 54 | negative regulation of ligase activity (GO:0051352) | 4.33763933 |
| 55 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.33763933 |
| 56 | cellular glucuronidation (GO:0052695) | 4.33560339 |
| 57 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.31950874 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.31671323 |
| 59 | serine family amino acid metabolic process (GO:0009069) | 4.29593314 |
| 60 | serine family amino acid biosynthetic process (GO:0009070) | 4.28729125 |
| 61 | ribosome assembly (GO:0042255) | 4.25552798 |
| 62 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.24565586 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.22577564 |
| 64 | negative regulation of sterol transport (GO:0032372) | 4.20980162 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 4.20980162 |
| 66 | phospholipid efflux (GO:0033700) | 4.17835479 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 4.14819926 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.13089313 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.12771283 |
| 70 | aldehyde catabolic process (GO:0046185) | 4.11710879 |
| 71 | glutamate metabolic process (GO:0006536) | 4.10873103 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 4.10585378 |
| 73 | amine catabolic process (GO:0009310) | 4.10585378 |
| 74 | ethanol oxidation (GO:0006069) | 4.10349346 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 4.07599633 |
| 76 | low-density lipoprotein particle remodeling (GO:0034374) | 4.04737741 |
| 77 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.99967294 |
| 78 | ATP synthesis coupled proton transport (GO:0015986) | 3.99967294 |
| 79 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.96467896 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 3.95033479 |
| 81 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.93064036 |
| 82 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.93064036 |
| 83 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.93064036 |
| 84 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.91534108 |
| 85 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.91534108 |
| 86 | cofactor catabolic process (GO:0051187) | 3.89701991 |
| 87 | regulation of mitochondrial translation (GO:0070129) | 3.89412130 |
| 88 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.88961795 |
| 89 | cholesterol efflux (GO:0033344) | 3.88714091 |
| 90 | aspartate family amino acid catabolic process (GO:0009068) | 3.88102365 |
| 91 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.86242808 |
| 92 | arginine metabolic process (GO:0006525) | 3.85432920 |
| 93 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.83479681 |
| 94 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.83479681 |
| 95 | glucuronate metabolic process (GO:0019585) | 3.83347069 |
| 96 | uronic acid metabolic process (GO:0006063) | 3.83347069 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.83320149 |
| 98 | ketone body metabolic process (GO:1902224) | 3.81972594 |
| 99 | organic acid catabolic process (GO:0016054) | 3.81294726 |
| 100 | carboxylic acid catabolic process (GO:0046395) | 3.81294726 |
| 101 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.79372716 |
| 102 | fibrinolysis (GO:0042730) | 3.79198541 |
| 103 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.78909098 |
| 104 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.75108547 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 3.74871778 |
| 106 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.74558969 |
| 107 | plasma lipoprotein particle assembly (GO:0034377) | 3.73190978 |
| 108 | rRNA modification (GO:0000154) | 3.71756441 |
| 109 | positive regulation of ligase activity (GO:0051351) | 3.70731607 |
| 110 | drug catabolic process (GO:0042737) | 3.68177972 |
| 111 | cullin deneddylation (GO:0010388) | 3.66300084 |
| 112 | protein complex biogenesis (GO:0070271) | 3.66126815 |
| 113 | ribosomal large subunit biogenesis (GO:0042273) | 3.65099688 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.64222454 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62799943 |
| 116 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61736389 |
| 117 | establishment of integrated proviral latency (GO:0075713) | 3.61143337 |
| 118 | complement activation (GO:0006956) | 3.59352504 |
| 119 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.58526143 |
| 120 | chaperone-mediated protein transport (GO:0072321) | 3.58485841 |
| 121 | CENP-A containing nucleosome assembly (GO:0034080) | 3.57396409 |
| 122 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55536890 |
| 123 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.55468491 |
| 124 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.55468491 |
| 125 | fatty acid beta-oxidation (GO:0006635) | 3.55200282 |
| 126 | cholesterol homeostasis (GO:0042632) | 3.55149999 |
| 127 | monocarboxylic acid catabolic process (GO:0072329) | 3.54743392 |
| 128 | protein activation cascade (GO:0072376) | 3.54092387 |
| 129 | fatty acid oxidation (GO:0019395) | 3.51683615 |
| 130 | positive regulation of lipid catabolic process (GO:0050996) | 3.51434602 |
| 131 | regulation of bile acid biosynthetic process (GO:0070857) | 3.49488227 |
| 132 | cytolysis (GO:0019835) | 3.48454518 |
| 133 | sterol homeostasis (GO:0055092) | 3.48452206 |
| 134 | lipid oxidation (GO:0034440) | 3.47541569 |
| 135 | intestinal cholesterol absorption (GO:0030299) | 3.47358202 |
| 136 | respiratory electron transport chain (GO:0022904) | 3.46107248 |
| 137 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.44882169 |
| 138 | mitotic metaphase plate congression (GO:0007080) | 3.43894524 |
| 139 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.41878634 |
| 140 | DNA replication checkpoint (GO:0000076) | 3.40676226 |
| 141 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.40641287 |
| 142 | electron transport chain (GO:0022900) | 3.40230826 |
| 143 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.38874609 |
| 144 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.38874609 |
| 145 | NADH dehydrogenase complex assembly (GO:0010257) | 3.38874609 |
| 146 | purine nucleobase biosynthetic process (GO:0009113) | 3.37336287 |
| 147 | protein deneddylation (GO:0000338) | 3.36918002 |
| 148 | chromatin remodeling at centromere (GO:0031055) | 3.36628444 |
| 149 | DNA strand elongation (GO:0022616) | 3.33607151 |
| 150 | regulation of ligase activity (GO:0051340) | 3.30759957 |
| 151 | rRNA methylation (GO:0031167) | 3.30466463 |
| 152 | respiratory chain complex IV assembly (GO:0008535) | 3.25479484 |
| 153 | inner mitochondrial membrane organization (GO:0007007) | 3.24746688 |
| 154 | pseudouridine synthesis (GO:0001522) | 3.24267464 |
| 155 | telomere maintenance via recombination (GO:0000722) | 3.22635806 |
| 156 | metaphase plate congression (GO:0051310) | 3.17511614 |
| 157 | protein targeting to mitochondrion (GO:0006626) | 3.16575941 |
| 158 | branched-chain amino acid catabolic process (GO:0009083) | 3.15417590 |
| 159 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.15240434 |
| 160 | regulation of cellular amine metabolic process (GO:0033238) | 3.13828650 |
| 161 | mitotic recombination (GO:0006312) | 3.10140310 |
| 162 | oxidative phosphorylation (GO:0006119) | 3.09479902 |
| 163 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.09048803 |
| 164 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.08917089 |
| 165 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.08876171 |
| 166 | nucleobase biosynthetic process (GO:0046112) | 3.06956398 |
| 167 | maturation of 5.8S rRNA (GO:0000460) | 3.06880491 |
| 168 | spliceosomal snRNP assembly (GO:0000387) | 3.06065127 |
| 169 | negative regulation of protein ubiquitination (GO:0031397) | 3.05130734 |
| 170 | cytochrome complex assembly (GO:0017004) | 3.04521485 |
| 171 | establishment of viral latency (GO:0019043) | 3.01921374 |
| 172 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.00915327 |
| 173 | positive regulation of cell cycle arrest (GO:0071158) | 3.00590446 |
| 174 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.99221107 |
| 175 | tRNA aminoacylation (GO:0043039) | 2.99106414 |
| 176 | amino acid activation (GO:0043038) | 2.99106414 |
| 177 | cell cycle G1/S phase transition (GO:0044843) | 2.98932363 |
| 178 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.98932363 |
| 179 | tricarboxylic acid cycle (GO:0006099) | 2.98576834 |
| 180 | formation of translation preinitiation complex (GO:0001731) | 2.97868275 |
| 181 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.97829275 |
| 182 | termination of RNA polymerase III transcription (GO:0006386) | 2.96503614 |
| 183 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.96503614 |
| 184 | tRNA aminoacylation for protein translation (GO:0006418) | 2.96060585 |
| 185 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.95010124 |
| 186 | cellular component biogenesis (GO:0044085) | 2.92168177 |
| 187 | protein localization to mitochondrion (GO:0070585) | 2.90368611 |
| 188 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.89498610 |
| 189 | establishment of protein localization to mitochondrion (GO:0072655) | 2.88396926 |
| 190 | translation (GO:0006412) | 2.88226201 |
| 191 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.85421708 |
| 192 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.83522481 |
| 193 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.83414189 |
| 194 | ribosome biogenesis (GO:0042254) | 2.83157256 |
| 195 | DNA ligation (GO:0006266) | 2.83109922 |
| 196 | telomere maintenance via telomere lengthening (GO:0010833) | 2.82103710 |
| 197 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.81455406 |
| 198 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.81172250 |
| 199 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.81172250 |
| 200 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.78601990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.07718024 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.95479183 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.83569772 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.19153192 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.27387288 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.21232873 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.11094158 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.02784639 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.39546817 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.19753538 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.80063620 |
| 12 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.70239121 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.68126808 |
| 14 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.53535877 |
| 15 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.29984278 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.21157216 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.02412752 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.96586805 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.88751448 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.83577919 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.77710408 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.66326929 |
| 23 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.61613877 |
| 24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.57068605 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.56618463 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.56508661 |
| 27 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.49215440 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.48072443 |
| 29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.46385781 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35927193 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.33397786 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.28213246 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.18879104 |
| 34 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.14870251 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.08826104 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 2.07580316 |
| 37 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.04726863 |
| 38 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.03922731 |
| 39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7936786 |
| 40 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.99516983 |
| 41 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95062374 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.94638256 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.90737508 |
| 44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.87562308 |
| 45 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.86098609 |
| 46 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.83767958 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.82335177 |
| 48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74615473 |
| 49 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.73526581 |
| 50 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.67772886 |
| 51 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.64978344 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61887498 |
| 53 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.59551037 |
| 54 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59526585 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52847769 |
| 56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48127565 |
| 57 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.45142843 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.43933273 |
| 59 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.43753789 |
| 60 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40569044 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39499874 |
| 62 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35657724 |
| 63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34736417 |
| 64 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.32707783 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32302271 |
| 66 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32022230 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28852567 |
| 68 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.27775166 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25846468 |
| 70 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25787768 |
| 71 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.24942794 |
| 72 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.23192962 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22660818 |
| 74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19790942 |
| 75 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19539867 |
| 76 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17783988 |
| 77 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.15600013 |
| 78 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14914917 |
| 79 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14826397 |
| 80 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14665501 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14189399 |
| 82 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10628673 |
| 83 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.05289027 |
| 84 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.05267989 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04247963 |
| 86 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.02194825 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02054775 |
| 88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01403970 |
| 89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00138546 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99930418 |
| 91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98246894 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96983735 |
| 93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96508525 |
| 94 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95229051 |
| 95 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93980114 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92797570 |
| 97 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92710966 |
| 98 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.90796028 |
| 99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90530890 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88098073 |
| 101 | EWS_26573619_Chip-Seq_HEK293_Human | 0.87288844 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87062509 |
| 103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86339454 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84936004 |
| 105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83225775 |
| 106 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.81207094 |
| 107 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.79616569 |
| 108 | FUS_26573619_Chip-Seq_HEK293_Human | 0.78215622 |
| 109 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.78106137 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76042807 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73269950 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.73252075 |
| 113 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.72882169 |
| 114 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.72764214 |
| 115 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.72109470 |
| 116 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71960222 |
| 117 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.71809546 |
| 118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71347907 |
| 119 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.70881021 |
| 120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70619060 |
| 121 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70017500 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69944528 |
| 123 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.69750731 |
| 124 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.69410618 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69109737 |
| 126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67356590 |
| 127 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.67132916 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66306952 |
| 129 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65285107 |
| 130 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64814757 |
| 131 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64814757 |
| 132 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62987757 |
| 133 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.62038882 |
| 134 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.61139955 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60263209 |
| 136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59133070 |
| 137 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.57287535 |
| 138 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56552804 |
| 139 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.55211402 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54941214 |
| 141 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.54891937 |
| 142 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53838212 |
| 143 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.51890324 |
| 144 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.51047623 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50878538 |
| 146 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.50577421 |
| 147 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.50446333 |
| 148 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49820286 |
| 149 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49683594 |
| 150 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.49500053 |
| 151 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49217277 |
| 152 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48825048 |
| 153 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48668250 |
| 154 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47032461 |
| 155 | * AR_21909140_ChIP-Seq_LNCAP_Human | 0.46827027 |
| 156 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.45822542 |
| 157 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45606145 |
| 158 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.45579990 |
| 159 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.45312594 |
| 160 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.45015571 |
| 161 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.44078265 |
| 162 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.43885120 |
| 163 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.43232695 |
| 164 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42763841 |
| 165 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41562526 |
| 166 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.41422410 |
| 167 | NCOR_22424771_ChIP-Seq_293T_Human | 0.40568312 |
| 168 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40367428 |
| 169 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.40304492 |
| 170 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.39963199 |
| 171 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38262121 |
| 172 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.38104261 |
| 173 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.36708195 |
| 174 | GATA2_19941826_ChIP-Seq_K562_Human | 0.36293686 |
| 175 | GATA1_19941826_ChIP-Seq_K562_Human | 0.36272540 |
| 176 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.36214152 |
| 177 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.35926404 |
| 178 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.35241076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.17379455 |
| 2 | MP0005360_urolithiasis | 7.28962266 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.41951134 |
| 4 | MP0005365_abnormal_bile_salt | 6.15365460 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.92332238 |
| 6 | * MP0003806_abnormal_nucleotide_metabolis | 4.21644166 |
| 7 | MP0010094_abnormal_chromosome_stability | 3.95441591 |
| 8 | MP0003693_abnormal_embryo_hatching | 3.87186976 |
| 9 | MP0008058_abnormal_DNA_repair | 3.74264911 |
| 10 | MP0003252_abnormal_bile_duct | 3.69165612 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 3.50148623 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.42774255 |
| 13 | MP0005083_abnormal_biliary_tract | 3.42736231 |
| 14 | MP0009840_abnormal_foam_cell | 3.06208220 |
| 15 | MP0008007_abnormal_cellular_replicative | 2.96289709 |
| 16 | MP0005332_abnormal_amino_acid | 2.93406306 |
| 17 | MP0003195_calcinosis | 2.92841186 |
| 18 | MP0003111_abnormal_nucleus_morphology | 2.87250616 |
| 19 | MP0003077_abnormal_cell_cycle | 2.82771455 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.82174773 |
| 21 | MP0003950_abnormal_plasma_membrane | 2.57328179 |
| 22 | MP0003786_premature_aging | 2.55505902 |
| 23 | MP0003941_abnormal_skin_development | 2.47641581 |
| 24 | MP0008932_abnormal_embryonic_tissue | 2.31352364 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.09150646 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.05322902 |
| 27 | * MP0000609_abnormal_liver_physiology | 2.05194004 |
| 28 | MP0009697_abnormal_copulation | 2.05068262 |
| 29 | MP0003868_abnormal_feces_composition | 2.00101706 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.98246756 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.87238267 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.87177844 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.86950272 |
| 34 | MP0002163_abnormal_gland_morphology | 1.77605638 |
| 35 | MP0008057_abnormal_DNA_replication | 1.77351847 |
| 36 | MP0000358_abnormal_cell_content/ | 1.75865293 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.74628267 |
| 38 | MP0003186_abnormal_redox_activity | 1.66991023 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63347068 |
| 40 | MP0005379_endocrine/exocrine_gland_phen | 1.60061187 |
| 41 | MP0002938_white_spotting | 1.59949811 |
| 42 | * MP0001764_abnormal_homeostasis | 1.57633292 |
| 43 | MP0000647_abnormal_sebaceous_gland | 1.45067670 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.37855174 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.34879948 |
| 46 | MP0005451_abnormal_body_composition | 1.33745007 |
| 47 | MP0002160_abnormal_reproductive_system | 1.32935092 |
| 48 | MP0005501_abnormal_skin_physiology | 1.31908019 |
| 49 | MP0001881_abnormal_mammary_gland | 1.31336558 |
| 50 | MP0003011_delayed_dark_adaptation | 1.29013813 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.24510107 |
| 52 | MP0006072_abnormal_retinal_apoptosis | 1.21333298 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.20190217 |
| 54 | MP0001216_abnormal_epidermal_layer | 1.17679074 |
| 55 | MP0001727_abnormal_embryo_implantation | 1.17214166 |
| 56 | MP0002090_abnormal_vision | 1.16450931 |
| 57 | MP0001697_abnormal_embryo_size | 1.16362354 |
| 58 | MP0000350_abnormal_cell_proliferation | 1.15519385 |
| 59 | * MP0000598_abnormal_liver_morphology | 1.15303479 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.14442016 |
| 61 | MP0002006_tumorigenesis | 1.11453481 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.11277073 |
| 63 | MP0005647_abnormal_sex_gland | 1.10272306 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 1.09837924 |
| 65 | MP0002796_impaired_skin_barrier | 1.08208283 |
| 66 | MP0006054_spinal_hemorrhage | 1.07475208 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 1.06673446 |
| 68 | MP0005389_reproductive_system_phenotype | 1.04659259 |
| 69 | MP0010678_abnormal_skin_adnexa | 1.03552121 |
| 70 | MP0001529_abnormal_vocalization | 1.03108490 |
| 71 | MP0000627_abnormal_mammary_gland | 1.02945245 |
| 72 | MP0001730_embryonic_growth_arrest | 1.02751117 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.01651649 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 1.00423162 |
| 75 | MP0005410_abnormal_fertilization | 1.00419926 |
| 76 | MP0005408_hypopigmentation | 0.98329129 |
| 77 | MP0009763_increased_sensitivity_to | 0.97178966 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 0.95911422 |
| 79 | MP0000604_amyloidosis | 0.94651136 |
| 80 | MP0000427_abnormal_hair_cycle | 0.93766365 |
| 81 | MP0005670_abnormal_white_adipose | 0.92915953 |
| 82 | MP0009764_decreased_sensitivity_to | 0.92290239 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.91836533 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 0.91709089 |
| 85 | MP0000313_abnormal_cell_death | 0.91323169 |
| 86 | MP0003315_abnormal_perineum_morphology | 0.89434315 |
| 87 | MP0010386_abnormal_urinary_bladder | 0.87602442 |
| 88 | MP0010771_integument_phenotype | 0.87203679 |
| 89 | MP0002080_prenatal_lethality | 0.87084670 |
| 90 | MP0009642_abnormal_blood_homeostasis | 0.85815378 |
| 91 | MP0008469_abnormal_protein_level | 0.82425033 |
| 92 | MP0010368_abnormal_lymphatic_system | 0.82184098 |
| 93 | * MP0005376_homeostasis/metabolism_phenot | 0.81194084 |
| 94 | MP0010307_abnormal_tumor_latency | 0.81179915 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 0.81062132 |
| 96 | MP0002210_abnormal_sex_determination | 0.78775334 |
| 97 | MP0002078_abnormal_glucose_homeostasis | 0.77963416 |
| 98 | MP0001929_abnormal_gametogenesis | 0.77528764 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.77257151 |
| 100 | MP0002254_reproductive_system_inflammat | 0.76532133 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.75369107 |
| 102 | MP0004130_abnormal_muscle_cell | 0.74144122 |
| 103 | MP0000613_abnormal_salivary_gland | 0.72953527 |
| 104 | MP0000383_abnormal_hair_follicle | 0.72085021 |
| 105 | MP0001661_extended_life_span | 0.71833594 |
| 106 | MP0008877_abnormal_DNA_methylation | 0.71323490 |
| 107 | MP0005174_abnormal_tail_pigmentation | 0.70438429 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.70349437 |
| 109 | MP0006292_abnormal_olfactory_placode | 0.69572189 |
| 110 | MP0001191_abnormal_skin_condition | 0.69405844 |
| 111 | MP0000749_muscle_degeneration | 0.68755483 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.68048967 |
| 113 | MP0002166_altered_tumor_susceptibility | 0.67317665 |
| 114 | MP0001756_abnormal_urination | 0.67233529 |
| 115 | * MP0005266_abnormal_metabolism | 0.66099616 |
| 116 | MP0002971_abnormal_brown_adipose | 0.65934350 |
| 117 | MP0004215_abnormal_myocardial_fiber | 0.65928851 |
| 118 | MP0000653_abnormal_sex_gland | 0.65001958 |
| 119 | MP0001919_abnormal_reproductive_system | 0.64838259 |
| 120 | MP0002095_abnormal_skin_pigmentation | 0.64765793 |
| 121 | MP0005380_embryogenesis_phenotype | 0.64314012 |
| 122 | MP0001672_abnormal_embryogenesis/_devel | 0.64314012 |
| 123 | MP0000569_abnormal_digit_pigmentation | 0.64178839 |
| 124 | MP0001145_abnormal_male_reproductive | 0.62467097 |
| 125 | MP0005334_abnormal_fat_pad | 0.61520663 |
| 126 | MP0003329_amyloid_beta_deposits | 0.60891883 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.57724149 |
| 128 | MP0003718_maternal_effect | 0.56702265 |
| 129 | MP0004147_increased_porphyrin_level | 0.56678501 |
| 130 | MP0003690_abnormal_glial_cell | 0.56144142 |
| 131 | * MP0005535_abnormal_body_temperature | 0.53040579 |
| 132 | MP0005448_abnormal_energy_balance | 0.51799084 |
| 133 | MP0009053_abnormal_anal_canal | 0.50899284 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.49860136 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.48924458 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.48201037 |
| 137 | MP0005395_other_phenotype | 0.48001862 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.46147784 |
| 139 | MP0008873_increased_physiological_sensi | 0.43864144 |
| 140 | MP0005666_abnormal_adipose_tissue | 0.42626911 |
| 141 | MP0001243_abnormal_dermal_layer | 0.41828352 |
| 142 | MP0003953_abnormal_hormone_level | 0.40599809 |
| 143 | MP0005464_abnormal_platelet_physiology | 0.40267408 |
| 144 | MP0004043_abnormal_pH_regulation | 0.39521577 |
| 145 | MP0008872_abnormal_physiological_respon | 0.39029669 |
| 146 | MP0009672_abnormal_birth_weight | 0.37168568 |
| 147 | MP0001853_heart_inflammation | 0.36570419 |
| 148 | MP0002269_muscular_atrophy | 0.35598901 |
| 149 | MP0002822_catalepsy | 0.35018147 |
| 150 | MP0005166_decreased_susceptibility_to | 0.32865364 |
| 151 | MP0008874_decreased_physiological_sensi | 0.32593873 |
| 152 | MP0002928_abnormal_bile_duct | 0.32054506 |
| 153 | MP0002132_abnormal_respiratory_system | 0.31495841 |
| 154 | MP0003075_altered_response_to | 0.31271024 |
| 155 | MP0005058_abnormal_lysosome_morphology | 0.29707916 |
| 156 | MP0002970_abnormal_white_adipose | 0.29690191 |
| 157 | MP0005165_increased_susceptibility_to | 0.29559461 |
| 158 | MP0002060_abnormal_skin_morphology | 0.29210242 |
| 159 | MP0005330_cardiomyopathy | 0.28574943 |
| 160 | MP0009115_abnormal_fat_cell | 0.27735559 |
| 161 | MP0000249_abnormal_blood_vessel | 0.26448536 |
| 162 | MP0003724_increased_susceptibility_to | 0.26088453 |
| 163 | MP0005595_abnormal_vascular_smooth | 0.25948345 |
| 164 | MP0002295_abnormal_pulmonary_circulatio | 0.25716548 |
| 165 | MP0001542_abnormal_bone_strength | 0.25329416 |
| 166 | MP0000579_abnormal_nail_morphology | 0.24789953 |
| 167 | MP0005023_abnormal_wound_healing | 0.23661623 |
| 168 | MP0008438_abnormal_cutaneous_collagen | 0.23346289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.14283815 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.09928944 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.73858773 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.37962506 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.13320658 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.00420062 |
| 7 | Xanthomatosis (HP:0000991) | 5.96809971 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 5.22910198 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.22375450 |
| 10 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.99735410 |
| 11 | Acute encephalopathy (HP:0006846) | 4.91463687 |
| 12 | Complement deficiency (HP:0004431) | 4.85772430 |
| 13 | Hyperammonemia (HP:0001987) | 4.73772181 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.60856285 |
| 15 | Progressive macrocephaly (HP:0004481) | 4.44578330 |
| 16 | Hyperglycinemia (HP:0002154) | 4.41566165 |
| 17 | Mitochondrial inheritance (HP:0001427) | 4.40606329 |
| 18 | Increased CSF lactate (HP:0002490) | 4.27967624 |
| 19 | Ketosis (HP:0001946) | 4.27867556 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19877200 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.19418058 |
| 22 | Fat malabsorption (HP:0002630) | 4.15789051 |
| 23 | Joint hemorrhage (HP:0005261) | 4.13331886 |
| 24 | Epidermoid cyst (HP:0200040) | 4.11889841 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 4.10256217 |
| 26 | Hypoglycemic coma (HP:0001325) | 4.09930584 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 4.00596009 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.98931095 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.98931095 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.98214986 |
| 31 | Hyperglycinuria (HP:0003108) | 3.96692492 |
| 32 | * Abnormality of methionine metabolism (HP:0010901) | 3.94664421 |
| 33 | Hepatocellular necrosis (HP:0001404) | 3.90683730 |
| 34 | * Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.89827961 |
| 35 | * Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.89712045 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77477946 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 3.76898731 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.67280530 |
| 39 | Lipid accumulation in hepatocytes (HP:0006561) | 3.64894965 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.59681630 |
| 41 | Abnormality of complement system (HP:0005339) | 3.50556550 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.49120416 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.47453655 |
| 44 | Increased serum pyruvate (HP:0003542) | 3.46314142 |
| 45 | Abnormal protein glycosylation (HP:0012346) | 3.31845771 |
| 46 | Abnormal glycosylation (HP:0012345) | 3.31845771 |
| 47 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.31845771 |
| 48 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.31845771 |
| 49 | Hypercholesterolemia (HP:0003124) | 3.31110071 |
| 50 | Abnormality of glycolysis (HP:0004366) | 3.30809169 |
| 51 | Increased serum lactate (HP:0002151) | 3.29279043 |
| 52 | Steatorrhea (HP:0002570) | 3.27528340 |
| 53 | * Hyperbilirubinemia (HP:0002904) | 3.24577437 |
| 54 | Reduced antithrombin III activity (HP:0001976) | 3.23652897 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 3.21471214 |
| 56 | Ketoacidosis (HP:0001993) | 3.20894508 |
| 57 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.19637436 |
| 58 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.19637436 |
| 59 | Delayed CNS myelination (HP:0002188) | 3.18030136 |
| 60 | Renal Fanconi syndrome (HP:0001994) | 3.17784160 |
| 61 | Lactic acidosis (HP:0003128) | 3.16717148 |
| 62 | Microvesicular hepatic steatosis (HP:0001414) | 2.97623575 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97500096 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.96409084 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.96409084 |
| 66 | Increased intramyocellular lipid droplets (HP:0012240) | 2.92751421 |
| 67 | Exercise intolerance (HP:0003546) | 2.92096871 |
| 68 | Metabolic acidosis (HP:0001942) | 2.90028961 |
| 69 | Lethargy (HP:0001254) | 2.88950639 |
| 70 | Hepatocellular carcinoma (HP:0001402) | 2.87332570 |
| 71 | Cerebral edema (HP:0002181) | 2.86704820 |
| 72 | Respiratory failure (HP:0002878) | 2.82673600 |
| 73 | 3-Methylglutaconic aciduria (HP:0003535) | 2.81496279 |
| 74 | Methylmalonic acidemia (HP:0002912) | 2.74963902 |
| 75 | Skin nodule (HP:0200036) | 2.70074264 |
| 76 | Amniotic constriction ring (HP:0009775) | 2.68514821 |
| 77 | Abnormality of placental membranes (HP:0011409) | 2.68514821 |
| 78 | Gout (HP:0001997) | 2.68439811 |
| 79 | Spontaneous abortion (HP:0005268) | 2.66997921 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.62609878 |
| 81 | Sparse eyelashes (HP:0000653) | 2.59920051 |
| 82 | Acanthocytosis (HP:0001927) | 2.59721178 |
| 83 | Abnormality of the preputium (HP:0100587) | 2.58520300 |
| 84 | Abnormal gallbladder morphology (HP:0012437) | 2.58303784 |
| 85 | Vascular calcification (HP:0004934) | 2.56314667 |
| 86 | Generalized aminoaciduria (HP:0002909) | 2.50633326 |
| 87 | Myocardial infarction (HP:0001658) | 2.50385490 |
| 88 | Abnormal gallbladder physiology (HP:0012438) | 2.50050951 |
| 89 | Cholecystitis (HP:0001082) | 2.50050951 |
| 90 | Cholelithiasis (HP:0001081) | 2.49291950 |
| 91 | Increased muscle lipid content (HP:0009058) | 2.47030520 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.41945602 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 2.41945602 |
| 94 | Hyperalaninemia (HP:0003348) | 2.41945602 |
| 95 | Hypochromic microcytic anemia (HP:0004840) | 2.40040873 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.38762052 |
| 97 | Leukodystrophy (HP:0002415) | 2.37958283 |
| 98 | Hypokinesia (HP:0002375) | 2.37706098 |
| 99 | Abnormality of the anterior horn cell (HP:0006802) | 2.36837590 |
| 100 | Degeneration of anterior horn cells (HP:0002398) | 2.36837590 |
| 101 | CNS demyelination (HP:0007305) | 2.34935301 |
| 102 | Methylmalonic aciduria (HP:0012120) | 2.34762032 |
| 103 | Malnutrition (HP:0004395) | 2.33752706 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.29162218 |
| 105 | Spastic diplegia (HP:0001264) | 2.29053768 |
| 106 | Cardiovascular calcification (HP:0011915) | 2.27614507 |
| 107 | Irritability (HP:0000737) | 2.27562807 |
| 108 | Vomiting (HP:0002013) | 2.27469273 |
| 109 | Late onset (HP:0003584) | 2.27013037 |
| 110 | Enlarged kidneys (HP:0000105) | 2.25997952 |
| 111 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.25836508 |
| 112 | Neoplasm of the adrenal gland (HP:0100631) | 2.25734444 |
| 113 | Exertional dyspnea (HP:0002875) | 2.25734009 |
| 114 | Neonatal onset (HP:0003623) | 2.20236748 |
| 115 | Chromsome breakage (HP:0040012) | 2.19848660 |
| 116 | Sensorimotor neuropathy (HP:0007141) | 2.18477445 |
| 117 | Brushfield spots (HP:0001088) | 2.15614509 |
| 118 | Opisthotonus (HP:0002179) | 2.15556215 |
| 119 | Abnormality of chromosome stability (HP:0003220) | 2.15518402 |
| 120 | Palpitations (HP:0001962) | 2.14263863 |
| 121 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.13765425 |
| 122 | Mitral stenosis (HP:0001718) | 2.13380748 |
| 123 | Meckel diverticulum (HP:0002245) | 2.12997082 |
| 124 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.12992545 |
| 125 | Pancreatitis (HP:0001733) | 2.12821975 |
| 126 | Conjunctival hamartoma (HP:0100780) | 2.11256665 |
| 127 | Abnormality of renal resorption (HP:0011038) | 2.09928441 |
| 128 | Glomerulonephritis (HP:0000099) | 2.09498679 |
| 129 | Abnormality of the gallbladder (HP:0005264) | 2.09306849 |
| 130 | Abnormal tarsal ossification (HP:0008369) | 2.06898107 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 2.06306035 |
| 132 | Amyloidosis (HP:0011034) | 2.06274760 |
| 133 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.04310613 |
| 134 | Renal cortical cysts (HP:0000803) | 2.03091789 |
| 135 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03000120 |
| 136 | Proximal tubulopathy (HP:0000114) | 2.02614990 |
| 137 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.02277884 |
| 138 | Optic disc pallor (HP:0000543) | 2.02184644 |
| 139 | Abnormality of the ileum (HP:0001549) | 1.98574319 |
| 140 | Poikilocytosis (HP:0004447) | 1.98319779 |
| 141 | Congenital, generalized hypertrichosis (HP:0004540) | 1.94403366 |
| 142 | Glycosuria (HP:0003076) | 1.94020282 |
| 143 | Abnormality of urine glucose concentration (HP:0011016) | 1.94020282 |
| 144 | Abnormal number of erythroid precursors (HP:0012131) | 1.93972654 |
| 145 | Dry hair (HP:0011359) | 1.93005352 |
| 146 | Pancytopenia (HP:0001876) | 1.92692288 |
| 147 | Testicular atrophy (HP:0000029) | 1.91455786 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 1.90107730 |
| 149 | Nausea (HP:0002018) | 1.89006579 |
| 150 | Respiratory difficulties (HP:0002880) | 1.88883836 |
| 151 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88841803 |
| 152 | Oral leukoplakia (HP:0002745) | 1.87229932 |
| 153 | Esophageal varix (HP:0002040) | 1.86280863 |
| 154 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.85684598 |
| 155 | Hydroxyprolinuria (HP:0003080) | 1.84651582 |
| 156 | Abnormality of proline metabolism (HP:0010907) | 1.84651582 |
| 157 | Abnormality of vitamin metabolism (HP:0100508) | 1.84466103 |
| 158 | Hepatic necrosis (HP:0002605) | 1.84284491 |
| 159 | Onycholysis (HP:0001806) | 1.84142697 |
| 160 | Rickets (HP:0002748) | 1.82522825 |
| 161 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81363220 |
| 162 | Thrombophlebitis (HP:0004418) | 1.81029575 |
| 163 | Neuroendocrine neoplasm (HP:0100634) | 1.80879888 |
| 164 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.80879156 |
| 165 | Increased purine levels (HP:0004368) | 1.80450465 |
| 166 | Hyperuricemia (HP:0002149) | 1.80450465 |
| 167 | Alkalosis (HP:0001948) | 1.79469220 |
| 168 | Aplastic anemia (HP:0001915) | 1.79138926 |
| 169 | Menorrhagia (HP:0000132) | 1.78066114 |
| 170 | Spastic paraparesis (HP:0002313) | 1.76696078 |
| 171 | Absent thumb (HP:0009777) | 1.75498606 |
| 172 | Macrocytic anemia (HP:0001972) | 1.75014568 |
| 173 | Poikiloderma (HP:0001029) | 1.72625012 |
| 174 | Small intestinal stenosis (HP:0012848) | 1.72406427 |
| 175 | Duodenal stenosis (HP:0100867) | 1.72406427 |
| 176 | Hypoplastic pelvis (HP:0008839) | 1.71390517 |
| 177 | Progressive muscle weakness (HP:0003323) | 1.70919261 |
| 178 | Multiple enchondromatosis (HP:0005701) | 1.68516432 |
| 179 | Tongue fasciculations (HP:0001308) | 1.68207395 |
| 180 | Myelodysplasia (HP:0002863) | 1.67461931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.35843591 |
| 2 | BUB1 | 3.83959977 |
| 3 | SIK1 | 3.80172434 |
| 4 | VRK2 | 3.71165488 |
| 5 | ERN1 | 3.59600903 |
| 6 | MST4 | 3.53151337 |
| 7 | FGFR4 | 3.53143058 |
| 8 | MAP3K12 | 2.78504637 |
| 9 | ERBB4 | 2.67087120 |
| 10 | INSRR | 2.49295376 |
| 11 | FLT3 | 2.47139307 |
| 12 | ZAK | 2.39139886 |
| 13 | PIK3CG | 2.24640814 |
| 14 | PKN2 | 2.21660537 |
| 15 | TAOK3 | 2.21182412 |
| 16 | CDC7 | 2.19057687 |
| 17 | STK38L | 2.17600539 |
| 18 | TSSK6 | 2.10377284 |
| 19 | SRPK1 | 2.01450258 |
| 20 | MAP2K4 | 1.90947188 |
| 21 | VRK1 | 1.90687785 |
| 22 | MST1R | 1.86690422 |
| 23 | MAPK11 | 1.78587499 |
| 24 | FRK | 1.78275557 |
| 25 | NEK9 | 1.77899802 |
| 26 | TTK | 1.74325746 |
| 27 | WEE1 | 1.72674645 |
| 28 | PLK3 | 1.72431173 |
| 29 | SCYL2 | 1.70495087 |
| 30 | TRIB3 | 1.70011721 |
| 31 | KDR | 1.62332111 |
| 32 | NUAK1 | 1.61401125 |
| 33 | ABL2 | 1.58759169 |
| 34 | EIF2AK1 | 1.54458136 |
| 35 | EPHA2 | 1.53688371 |
| 36 | PINK1 | 1.52718383 |
| 37 | NME1 | 1.51215831 |
| 38 | MAP3K3 | 1.48991237 |
| 39 | TAF1 | 1.46868051 |
| 40 | PLK4 | 1.45103956 |
| 41 | LIMK1 | 1.39509084 |
| 42 | LATS1 | 1.33941769 |
| 43 | CCNB1 | 1.32524119 |
| 44 | MAP2K3 | 1.31961138 |
| 45 | TRIM28 | 1.29156114 |
| 46 | PLK1 | 1.28654335 |
| 47 | MAPKAPK5 | 1.28104580 |
| 48 | TYK2 | 1.26284292 |
| 49 | EIF2AK2 | 1.23111102 |
| 50 | OBSCN | 1.22977809 |
| 51 | BMPR1B | 1.22461761 |
| 52 | MET | 1.22207047 |
| 53 | TLK1 | 1.15252573 |
| 54 | PDK3 | 1.11472092 |
| 55 | PDK4 | 1.11472092 |
| 56 | PAK4 | 1.09981162 |
| 57 | MYLK | 1.08789703 |
| 58 | CDK8 | 1.08674348 |
| 59 | DAPK2 | 1.08606366 |
| 60 | ERBB3 | 1.08199964 |
| 61 | AURKB | 1.07641833 |
| 62 | MAP4K2 | 1.06142374 |
| 63 | PBK | 1.04203717 |
| 64 | PIK3CA | 1.03744665 |
| 65 | NEK1 | 1.03599119 |
| 66 | TBK1 | 1.02826417 |
| 67 | PRKAA2 | 1.02325677 |
| 68 | PTK6 | 0.95249797 |
| 69 | FGFR2 | 0.93074806 |
| 70 | STK16 | 0.92014625 |
| 71 | EIF2AK3 | 0.91985669 |
| 72 | JAK2 | 0.88894613 |
| 73 | MAPK4 | 0.87968149 |
| 74 | MAP3K11 | 0.86600050 |
| 75 | TIE1 | 0.85724126 |
| 76 | MKNK1 | 0.84936465 |
| 77 | MAPK12 | 0.83737539 |
| 78 | BRSK1 | 0.81947137 |
| 79 | ATR | 0.80922464 |
| 80 | PIM2 | 0.80180674 |
| 81 | MAP3K7 | 0.79627595 |
| 82 | CHEK2 | 0.77849682 |
| 83 | PASK | 0.77411745 |
| 84 | DAPK1 | 0.77404345 |
| 85 | PRKACG | 0.76320021 |
| 86 | ERBB2 | 0.75660377 |
| 87 | MAPK15 | 0.73681325 |
| 88 | TESK1 | 0.73328032 |
| 89 | MAP2K6 | 0.73110148 |
| 90 | CAMK2G | 0.70952345 |
| 91 | PDK2 | 0.69164115 |
| 92 | STK24 | 0.68376011 |
| 93 | MKNK2 | 0.66945952 |
| 94 | RPS6KB2 | 0.66481394 |
| 95 | MUSK | 0.65939501 |
| 96 | PRKCZ | 0.64621258 |
| 97 | CDK7 | 0.63304132 |
| 98 | GRK6 | 0.61117102 |
| 99 | MAP2K1 | 0.60901424 |
| 100 | PRKAA1 | 0.58934265 |
| 101 | NME2 | 0.56649893 |
| 102 | AURKA | 0.56549219 |
| 103 | PHKG2 | 0.56291773 |
| 104 | PHKG1 | 0.56291773 |
| 105 | CSNK1A1L | 0.54034620 |
| 106 | CSNK2A1 | 0.52120897 |
| 107 | CDK6 | 0.51647003 |
| 108 | WNK4 | 0.51093777 |
| 109 | TGFBR1 | 0.51039282 |
| 110 | ATM | 0.50946736 |
| 111 | IGF1R | 0.50308811 |
| 112 | CSNK2A2 | 0.50070423 |
| 113 | ILK | 0.49923491 |
| 114 | PLK2 | 0.49889724 |
| 115 | PRKG2 | 0.49579915 |
| 116 | LMTK2 | 0.48609288 |
| 117 | MAP3K14 | 0.48105698 |
| 118 | PRKCI | 0.48060465 |
| 119 | CLK1 | 0.47726740 |
| 120 | MAPK7 | 0.47403685 |
| 121 | BCR | 0.46926295 |
| 122 | MAP3K5 | 0.46327761 |
| 123 | STK10 | 0.45992318 |
| 124 | CHEK1 | 0.45795633 |
| 125 | SGK223 | 0.44213168 |
| 126 | SGK494 | 0.44213168 |
| 127 | JAK1 | 0.43607342 |
| 128 | IRAK3 | 0.43429782 |
| 129 | SGK2 | 0.43173442 |
| 130 | TAOK2 | 0.43060969 |
| 131 | CSNK1G2 | 0.42678289 |
| 132 | GSK3A | 0.42636727 |
| 133 | RPS6KA4 | 0.42346220 |
| 134 | PDPK1 | 0.41990381 |
| 135 | NEK2 | 0.41734177 |
| 136 | SGK3 | 0.41251966 |
| 137 | TESK2 | 0.41094448 |
| 138 | MAP3K8 | 0.41092569 |
| 139 | PTK2 | 0.37381585 |
| 140 | BMPR2 | 0.37272737 |
| 141 | ADRBK2 | 0.37211180 |
| 142 | PRKCQ | 0.35205534 |
| 143 | STK39 | 0.34527417 |
| 144 | PRKCG | 0.31515614 |
| 145 | CDK4 | 0.30960563 |
| 146 | MAPKAPK3 | 0.30771179 |
| 147 | STK4 | 0.30521417 |
| 148 | PNCK | 0.30107291 |
| 149 | PRKCA | 0.29841617 |
| 150 | MAP2K2 | 0.29259892 |
| 151 | RPS6KA5 | 0.28832344 |
| 152 | CSNK1G1 | 0.28375301 |
| 153 | CAMK2D | 0.28060472 |
| 154 | WNK3 | 0.27454600 |
| 155 | RET | 0.27008841 |
| 156 | CDK9 | 0.26493357 |
| 157 | PRKACA | 0.25213656 |
| 158 | PRKACB | 0.24970016 |
| 159 | EPHA3 | 0.24879746 |
| 160 | IKBKB | 0.24407924 |
| 161 | LATS2 | 0.22758759 |
| 162 | PDK1 | 0.22737078 |
| 163 | IKBKE | 0.22567370 |
| 164 | MAPK3 | 0.21803887 |
| 165 | DYRK1B | 0.21635757 |
| 166 | TGFBR2 | 0.21225810 |
| 167 | BRSK2 | 0.20458020 |
| 168 | GRK1 | 0.20414092 |
| 169 | STK3 | 0.18916805 |
| 170 | CSF1R | 0.18559524 |
| 171 | DAPK3 | 0.18221698 |
| 172 | ARAF | 0.17355304 |
| 173 | CSNK1G3 | 0.16917716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.23071910 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45558430 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23358000 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18335647 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.00228257 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.98044337 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87083742 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.72515880 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67008555 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59224523 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58907269 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57876715 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.57012846 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.53001574 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.51263128 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 2.48039317 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 2.48003527 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.25260361 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 2.23569391 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19923717 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15105497 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 2.10087876 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09735489 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05551824 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89843826 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87455161 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83519177 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81218298 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77870810 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.77594415 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77592598 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75661087 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72973511 |
| 34 | Base excision repair_Homo sapiens_hsa03410 | 1.72765648 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.71807328 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71801983 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71269742 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.70659301 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68131067 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66232127 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 1.65371101 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65085430 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64200153 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60939636 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.55015029 |
| 46 | Spliceosome_Homo sapiens_hsa03040 | 1.54589361 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54345180 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53305905 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52699414 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49473192 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43901953 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40447177 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39409620 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39178564 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.38688443 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38654858 |
| 57 | RNA degradation_Homo sapiens_hsa03018 | 1.36039883 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36017373 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35432283 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33194020 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 1.30469350 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19180446 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.14496914 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13610515 |
| 65 | * Purine metabolism_Homo sapiens_hsa00230 | 1.12259606 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08725053 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06222453 |
| 68 | Cell cycle_Homo sapiens_hsa04110 | 1.04493389 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04206151 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 1.03633328 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.00412935 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98212874 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95416806 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92923078 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91833511 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91040870 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89636216 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88973509 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88707012 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86723788 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79805194 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72747451 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72057106 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69549661 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68851561 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.67036743 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61290356 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56685930 |
| 89 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56631438 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48034084 |
| 91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.45468305 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43803870 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38894935 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38854095 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36826430 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35805301 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34499813 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31308110 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.31274183 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26711955 |
| 101 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24538238 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23602567 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.22287529 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22244092 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21584614 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19122457 |
| 107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.17204394 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15794750 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.15701634 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13493132 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13403196 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12930872 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12040945 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08385976 |
| 115 | Protein export_Homo sapiens_hsa03060 | 0.02839912 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.01903675 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | -0.2216723 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1788684 |
| 119 | Proteasome_Homo sapiens_hsa03050 | -0.1680875 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1579038 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1371212 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1365494 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1312472 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1303522 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1289937 |
| 126 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1232634 |
| 127 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0933224 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0908079 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0769391 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0358847 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0266280 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0190200 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0179925 |
| 134 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0076173 |

